These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8177710)

  • 1. Cytokine gene transfer for the treatment of cancer.
    Bruyns C; Gérard C; Velu T
    Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S17-20. PubMed ID: 8177710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine gene transfer in cancer therapy.
    Cao L; Kulmburg P; Veelken H; Mackensen A; Mézes B; Lindemann A; Mertelsmann R; Rosenthal FM
    Stem Cells; 1998; 16 Suppl 1():251-60. PubMed ID: 11012169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer immunogene therapy.
    Yoshizawa H; Kagamu H; Gejyo F
    Arch Immunol Ther Exp (Warsz); 2001; 49(5):337-43. PubMed ID: 11798131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ cytokine gene transfection using vaccinia virus vectors.
    Lattime EC; Lee SS; Eisenlohr LC; Mastrangelo MJ
    Semin Oncol; 1996 Feb; 23(1):88-100. PubMed ID: 8607035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of cytokine gene transfer into tumors on host cell infiltration and regression.
    McBride WH; Economou JS; Syljuåsen RG; Parrish C; Hackman D; Latham V; Chiang CS; Dougherty GJ
    Anticancer Res; 1996; 16(3A):1139-43. PubMed ID: 8702225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D; Moyana T; Xiang J
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gene therapy of malignant tumors. Prospects of cytokine gene transfer vaccines].
    Bubeník J
    Cas Lek Cesk; 1997 Jan; 136(1):17-21. PubMed ID: 9147847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine and immuno-gene therapy for solid tumors.
    Li CY; Huang Q; Kung HF
    Cell Mol Immunol; 2005 Apr; 2(2):81-91. PubMed ID: 16191413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transfer approaches in cancer immunotherapy.
    Larin SS; Georgiev GP; Kiselev SL
    Gene Ther; 2004 Oct; 11 Suppl 1():S18-25. PubMed ID: 15454953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy approaches in urologic oncology.
    Vieweg J; Gilboa E
    Surg Oncol Clin N Am; 1995 Apr; 4(2):203-18. PubMed ID: 7796281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-alpha and HSVtk: perspectives for the generation of cancer vaccines.
    Santodonato L; D'Agostino G; Santini SM; Carlei D; Musiani P; Modesti A; Signorelli P; Belardelli F; Ferrantini M
    Gene Ther; 1997 Nov; 4(11):1246-55. PubMed ID: 9425449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy of tumor metastasis via gene therapy.
    Porgador A; Feldman M; Eisenbach L
    Nat Immun; 1994; 13(2-3):113-30. PubMed ID: 8173233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
    Hwang C; Sanda MG
    Curr Opin Mol Ther; 1999 Aug; 1(4):471-9. PubMed ID: 11713762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer.
    Cao X; Huang X; Ju DW; Zhang W; Hamada H; Wang J
    Cancer Gene Ther; 2000 Feb; 7(2):177-86. PubMed ID: 10770625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of a chemokine, cytokine and TCR-based T cell stimulus for effective gene therapy of cancer.
    Paul S; Regulier E; Poitevin Y; Hormann H; Acres RB
    Cancer Immunol Immunother; 2002 Dec; 51(11-12):645-54. PubMed ID: 12439610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient cotransduction of tumors by multiple herpes simplex vectors: implications for tumor vaccine production.
    Karpoff HM; Kooby D; D'Angelica M; Mack J; Presky DH; Brownlee MD; Federoff H; Fong Y
    Cancer Gene Ther; 2000 Apr; 7(4):581-8. PubMed ID: 10811476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumors.
    Liu Y; Saxena A; Zheng C; Carlsen S; Xiang J
    J Gene Med; 2004 Aug; 6(8):857-68. PubMed ID: 15293344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinational immunotherapy for established tumors with engineered tumor vaccines and adenovirus-mediated gene transfer.
    Xiang J; Chen Y; Moyana T
    Cancer Gene Ther; 2000 Jul; 7(7):1023-33. PubMed ID: 10917205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
    Becker Y
    Anticancer Res; 2006; 26(2A):1113-34. PubMed ID: 16619514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.